(Q41333143)

29 September 2017

1 reference

title

Dose-response of inhaled drugs in asthma. An update (English)

1 reference

29 September 2017

0 references

Clark DJ

1

1 reference

29 September 2017

Lipworth BJ

series ordinal

2

1 reference

29 September 2017

publication date

1 January 1997

1 reference

Clinical Pharmacokinetics

29 September 2017

published in

1 reference

29 September 2017

volume

32

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

58-74

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199732010-00003

29 September 2017

exact match

0 references

cites work

Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator

1 reference

12 December 2020

Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group

1 reference

12 December 2020

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

12 December 2020

A 1-week dose-ranging study of inhaled salmeterol in patients with asthma

1 reference

12 December 2020

Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients

1 reference

12 December 2020

Clinical pharmacology of corticosteroids in bronchial asthma

1 reference

12 December 2020

A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma

1 reference

12 December 2020

Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients

1 reference

12 December 2020

Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma

1 reference

12 December 2020

High dose inhaled steroid therapy and the cortisol stress response to acute severe asthma

1 reference

12 December 2020

The human pharmacology of fluticasone propionate

1 reference

12 December 2020

Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler

1 reference

12 December 2020

Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte beta 2-adrenoceptor function in asthmatic patients

1 reference

12 December 2020

Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects

1 reference

12 December 2020

High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group

1 reference

12 December 2020

Systemic effects of salbutamol and salmeterol in patients with asthma

1 reference

12 December 2020

High-dose beclomethasone inhaler in the treatment of asthma

1 reference

12 December 2020

Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium.

1 reference

12 December 2020

Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition

1 reference

12 December 2020

On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration

1 reference

12 December 2020

Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors in guinea-pig trachea

1 reference

12 December 2020

An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers.

1 reference

12 December 2020

Pharmacokinetics of budesonide in children with asthma

1 reference

12 December 2020

Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta- adrenoceptor agonists

1 reference

12 December 2020

Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol

1 reference

12 December 2020

Metabolism of beclomethasone dipropionate by animals and man

1 reference

12 December 2020

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

12 December 2020

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

1 reference

12 December 2020

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children

1 reference

12 December 2020

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma

1 reference

12 December 2020

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

12 December 2020

Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects

1 reference

12 December 2020

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

12 December 2020

Importance of the inhalation device on the effect of budesonide

1 reference

12 December 2020

High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society

1 reference

12 December 2020

The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma

1 reference

12 December 2020

Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma

1 reference

12 December 2020

Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria

1 reference

12 December 2020

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid

1 reference

12 December 2020

Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").

1 reference

12 December 2020

Bronchodilating effect of terbutaline powder in acute severe bronchial obstruction

1 reference

12 December 2020

The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro

1 reference

12 December 2020

The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone

1 reference

12 December 2020

Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids

1 reference

12 December 2020

Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease

1 reference

12 December 2020

Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone

1 reference

12 December 2020

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

1 reference

12 December 2020

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

1 reference

12 December 2020

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

1 reference

12 December 2020

Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover

1 reference

12 December 2020

Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism

1 reference

12 December 2020

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

1 reference

12 December 2020

Bioequivalent doses of budesonide and prednisone in moderate and severe asthma

1 reference

12 December 2020

A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group

1 reference

12 December 2020

Beta-adrenoceptor responses to inhaled salbutamol in normal subjects

1 reference

12 December 2020

Effects of short-term exposure to high-dose inhaled corticosteroids on novel markers of bone metabolism

1 reference

12 December 2020

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

1 reference

12 December 2020

A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects

1 reference

12 December 2020

Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma

1 reference

12 December 2020

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

12 December 2020

Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients

1 reference

12 December 2020

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

1 reference

12 December 2020

Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol

1 reference

12 December 2020

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

12 December 2020

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens

1 reference

12 December 2020

Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics

1 reference

12 December 2020

The inhalation device influences lung deposition and bronchodilating effect of terbutaline

1 reference

12 December 2020

Use of spacers to facilitate inhaled corticosteroid treatment of asthma

1 reference

12 December 2020

10.2165/00003088-199732010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

29 September 2017

1050782285

0 references

Fatcat ID

release_xe5n2w6vp5g3renqg74i54i6c4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xe5n2w6vp5g3renqg74i54i6c4

24 November 2022

mapped directly with Wikidata item

1 reference